Adipose tissue, diabetes and chagas disease

Advances in Parasitology

Volumn 76, Issue , 2011, Pages 235-250

  Tanowitz, Herbert B ^a   Jelicks, Linda A ^a   Machado, Fabiana S ^b   Esper, Lisia ^b   Qi, Xiaohua ^a   Desruisseaux, Mahalia S ^a   Chua, Streamson C ^a   Scherer, Philipp E ^c,d   Nagajyothi, Fnu ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adipocyte; Adipokines; Adiponectin; Adipose tissue; Chagas disease; Chemokines; Cytokines; Diabetes; Fat cell; Inflammation; Macrophage; Trypanosoma cruzi

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; CAVEOLIN 1; CERAMIDASE; CHEMOKINE RECEPTOR CXCR3; CYCLIN D1; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 33; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RANTES; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BOOK; CHAGAS DISEASE; CYTOKINE RELEASE; DIABETES MELLITUS; DRUG MECHANISM; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; IMMUNE DEFICIENCY; INFLAMMATION; INSULIN SENSITIVITY; MOLECULAR WEIGHT; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ZOONOSIS;

MUS; TRYPANOSOMA CRUZI;

EID: 80052163093     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385895-5.00010-4     Document Type: Chapter

References (75)

1. Anderson E.K., Gutierrez D.A., Hasty A.H. Adipose tissue recruitment of leukocytes. Curr. Opin. Lipidol. 2010, 21:172-177.
2. Andrade Z.A., Silva H.R. Parasitism of adipocytes by Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 1995, 90:521-522.
3. Anuurad E., Bremer A., Berglund L. HIV protease inhibitors and obesity. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17:478-485.
4. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
5. Asterholm I.W., Halberg N., Scherer P.E. Mouse models of lipodystrophy key reagents for the understanding of the metabolic syndrome. Drug Discov. Today Dis. Models 2007, 4:17-24.
6. Attie A.D., Scherer P.E. Adipocyte metabolism and obesity. J. Lipid Res. 2009, 50(Suppl.):S395-S399.
7. Bechah Y., Paddock C.D., Capo C., Mege J.L., Raoult D. Adipose tissue serves as a reservoir for recrudescent Rickettsia prowazekii infection in a mouse model. PLoS One 2010, 5:e8547.
8. Buckner F.S., Wilson A.J., Van Voorhis W.C. Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Infect. Immun. 1999, 67:403-409.
9. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., et al. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes. Res. 2005, 13:1311-1320.
10. Cohen A.W., Park D.S., Woodman S.E., Williams T.M., Chandra M., Shirani J., et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 2003, 284:C457-C474.
11. Cohen A.W., Hnasko R., Schubert W., Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol. Rev. 2004, 84:1341-1379.
12. Combs T.P., Berg A.H., Obici S., Scherer P.E., Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 2001, 108:1875-1881.
13. Combs T.P., Nagajyothi, Mukherjee S., de Almeida C.J., Jelicks L.A., Schubert W., et al. The adipocyte as an important target cell for Trypanosoma cruzi infection. J. Biol. Chem. 2005, 280:24085-24094.
14. Cook K.S., Min H.Y., Johnson D., Chaplinsky R.J., Flier J.S., Hunt C.R., et al. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 1987, 237:402-405.
15. de Luca C., Kowalski T.J., Zhang Y., Elmquist J.K., Lee C., Kilimann M.W., et al. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 2005, 115:3484-3493.
16. Desruisseaux M.S., Nagajyothi, Trujillo M.E., Tanowitz H.B., Scherer P.E. Adipocyte, adipose tissue, and infectious disease. Infect. Immun. 2007, 75:1066-1078.
17. dos Santos V.M., da Cunha S.F., Teixeira Vde P., Monteiro J.P., dos Santos J.A., dos Santos T.A., et al. Frequency of diabetes mellitus and hyperglycemia in chagasic and non-chagasic women. Rev. Soc. Bras. Med. Trop. 1999, 32:489-496.
18. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2002, 290:1084-1089.
19. Ferrante A.W. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med. 2007, 262:408-414.
20. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307:426-430.
21. Garrabou G., Lopez S., Moren C., Martinez E., Fontdevila J., Cardellach F., et al. Mitochondrial damage in adipose tissue of untreated HIV-infected patients. AIDS 2011, 25:165-170.
22. Geraix J., Ardisson L.P., Marcondes-Machado J., Pereira P.C. Clinical and nutritional profile of individuals with Chagas disease. Braz. J. Infect. Dis. 2007, 11:411-414.
23. Gerhardt C.C., Romero I.A., Cancello R., Camoin L., Strosberg A.D. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol. Cell. Endocrinol. 2001, 175:81-92.
24. Goldstein B.J., Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J. Clin. Endocrinol. Metab. 2004, 89:2563-2568.
25. Guariento M.E., Saad M.J., Muscelli E.O., Gontijo J.A. Heterogenous insulin response to an oral glucose load by patients with the indeterminate clinical form of Chagas' disease. Braz. J. Med. Biol. Res. 1993, 26:491-495.
26. Halberg N., Wernstedt-Asterholm I., Scherer P.E. The adipocyte as an endocrine cell. Endocrinol. Metab. Clin. North Am. 2008, 37:753-768. x-xi.
27. Hazan U., Romero I.A., Cancello R., Valente S., Perrin V., Mariot V., et al. Human adipose cells express CD4, CXCR4, and CCR5 [corrected] receptors: a new target cell type for the immunodeficiency virus-1?. FASEB J. 2002, 16:1254-1256.
28. Hidron A.I., Gilman R.H., Justiniano J., Blackstock A.J., Lafuente C., Selum W., et al. Chagas cardiomyopathy in the context of the chronic disease transition. PLoS Negl. Trop. Dis. 2010, 4:e688.
29. Holland W.L., Miller R.A., Wang Z.V., Sun K., Barth B.M., Bui H.H., et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 2011, 17:55-63.
30. Holscher C., Mohrs M., Dai W.J., Kohler G., Ryffel B., Schaub G.A., et al. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect. Immun. 2000, 68:4075-4083.
31. Horrillo R., Gonzalez-Periz A., Martinez-Clemente M., Lopez-Parra M., Ferre N., Titos E., et al. 5-Lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity. J. Immunol. 2010, 184:3978-3987.
32. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
33. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1595-1599.
34. Hulit J., Bash T., Fu M., Galbiati F., Albanese C., Sage D.R., et al. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J. Biol. Chem. 2000, 275:21203-21209.
35. Jan V., Cervera P., Maachi M., Baudrimont M., Kim M., Vidal H., et al. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Antivir. Ther. 2004, 9:555-564.
36. Kaminski D.A., Randall T.D. Adaptive immunity and adipose tissue biology. Trends Immunol. 2010, 31:384-390.
37. Karlsson E.A., Sheridan P.A., Beck M.A. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. J. Nutr. 2010, 140:1691-1697.
38. Keller P., Moller K., Krabbe K.S., Pedersen B.K. Circulating adiponectin levels during human endotoxaemia. Clin. Exp. Immunol. 2003, 134:107-110.
39. Kosteli A., Sugaru E., Haemmerle G., Martin J.F., Lei J., Zechner R., et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 2010, 120:3466-3479.
40. Lin Y., Rajala M.W., Berger J.P., Moller D.E., Barzilai N., Scherer P.E. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J. Biol. Chem. 2001, 276:42077-42083.
41. Long Q., Lei T., Feng B., Yin C., Jin D., Wu Y., et al. Peroxisome proliferator-activated receptor-gamma increases adiponectin secretion via transcriptional repression of endoplasmic reticulum chaperone protein ERp44. Endocrinology 2010, 151:3195-3203.
42. Maurin T., Saillan-Barreau C., Cousin B., Casteilla L., Doglio A., Penicaud L. Tumor necrosis factor-alpha stimulates HIV-1 production in primary culture of human adipocytes. Exp. Cell Res. 2005, 304:544-551.
43. Miller A.M., Asquith D.L., Hueber A.J., Anderson L.A., Holmes W.M., McKenzie A.N., et al. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ. Res. 2010, 107:650-658.
44. Mynarcik D.C., Combs T., McNurlan M.A., Scherer P.E., Komaroff E., Gelato M.C. Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution. J. Acquir. Immune Defic. Syndr. 2002, 31:514-520.
45. Nagajyothi F., Desruisseaux M.S., Thiruvur N., Weiss L.M., Braunstein V.L., Albanese C., et al. Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity 2008, 16:1992-1997.
46. Nagajyothi F., Zhao D., Machado F.S., Weiss L.M., Schwartz G.J., Desruisseaux M.S., et al. Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J. Infect. Dis. 2010, 202:1104-1113.
47. Nawrocki A.R., Scherer P.E. Keynote review: the adipocyte as a drug discovery target. Drug Discov. Today 2005, 10:1219-1230.
48. Okamoto Y., Folco E.J., Minami M., Wara A.K., Feinberg M.W., Sukhova G.K., et al. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ. Res. 2008, 102:218-225.
49. Oliveira L.C., Juliano Y., Novo N.F., Neves M.M. Blood glucose and insulin response to intravenous glucose by patients with chronic Chagas' disease and alcoholism. Braz. J. Med. Biol. Res. 1993, 26:1187-1190.
50. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000, 102:1296-1301.
51. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003, 14:561-566.
52. Ouchi N., Shibata R., Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc. Med. 2006, 16:141-146.
53. Pajvani U.B., Trujillo M.E., Combs T.P., Iyengar P., Jelicks L., Roth K.A., et al. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat. Med. 2005, 11:797-803.
54. Park S., Rich J., Hanses F., Lee J.C. Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect. Immun. 2009, 77:1008-1014.
55. Rajala M.W., Scherer P.E. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003, 144:3765-3773.
56. Ruan H., Lodish H.F. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 2003, 14:447-455.
57. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995, 270:26746-26749.
58. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 2004, 10:1384-1389.
59. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 2005, 11:1096-1103.
60. Shimano M., Ouchi N., Shibata R., Ohashi K., Pimentel D.R., Murohara T., et al. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. J. Mol. Cell. Cardiol. 2010, 49:210-220.
61. Shoemaker J.P., Hoffman R.V. Trypanosoma cruzi: possible stimulatory factor(s) on brown adipose tissue of mice. Exp. Parasitol. 1974, 35:272-274.
62. Shoemaker J.P., Hoffman R.V., Huffman D.G. Trypanosoma cruzi: preference for brown adipose tissue in mice by the Tulahuen strain. Exp. Parasitol. 1970, 27:403-407.
63. Stahl M., Ge C., Shi S., Pestell R.G., Stanley P. Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1. Cancer Res. 2006, 66:7562-7570.
64. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
65. Tanowitz H.B., Amole B., Hewlett D., Wittner M. Trypanosoma cruzi infection in diabetic mice. Trans. R. Soc. Trop. Med. Hyg. 1988, 82:90-93.
66. Tanowitz H.B., Machado F.S., Jelicks L.A., Shirani J., de Carvalho A.C., Spray D.C., et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog. Cardiovasc. Dis. 2009, 51:524-539.
67. Tsatsanis C., Margioris A.N., Kontoyiannis D.P. Association between H1N1 infection severity and obesity-adiponectin as a potential etiologic factor. J. Infect. Dis. 2010, 202:459-460.
68. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
69. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 2001, 86:3815-3819.
70. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362.
71. Yang R.Z., Lee M.J., Hu H., Pray J., Wu H.B., Hansen B.C., et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E1253-E1261.
72. Yang H., Youm Y.H., Vandanmagsar B., Ravussin A., Gimble J.M., Greenway F., et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol. 2010, 185:1836-1845.
73. Yudkin J.S. Inflammation, obesity, and the metabolic syndrome. Horm. Metab. Res. 2007, 39:707-709.
74. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
75. Zuniga L.A., Shen W.J., Joyce-Shaikh B., Pyatnova E.A., Richards A.G., Thom C., et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J. Immunol. 2010, 185:6947-6959.